Home > Boards > US Listed > Medical - Healthcare > SELLAS Life Sciences Group, Inc. (SLS)

Merck n Sellas Partnership will be next to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casenumber Member Profile
 
Followed By 75
Posts 4,120
Boards Moderated 0
Alias Born 06/28/11
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/14/2019 4:37:25 PM
SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results GlobeNewswire Inc. - 11/14/2019 4:30:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:19:18 PM
SELLAS to Host R&D Investor Event on Galinpepimut-S (GPS) and the Next Generation of Cancer Immunotherapy GlobeNewswire Inc. - 11/8/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 5:01:17 PM
SELLAS Announces Reverse Stock Split GlobeNewswire Inc. - 11/6/2019 9:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 6:05:18 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/30/2019 6:06:04 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/15/2019 6:01:14 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 10/4/2019 5:08:22 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/20/2019 4:14:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2019 4:31:16 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 4:26:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2019 4:20:46 PM
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2019 Financial Results GlobeNewswire Inc. - 8/14/2019 4:15:00 PM
SELLAS Announces Completion of Enrollment in Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carci... GlobeNewswire Inc. - 8/5/2019 8:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/5/2019 8:29:59 AM
SELLAS Advances Galinpepimut-S (GPS) in Combination with KEYTRUDA® (pembrolizumab) Program with Dosing of First Patient in P... GlobeNewswire Inc. - 7/31/2019 8:15:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 7/26/2019 5:01:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/18/2019 4:51:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/15/2019 4:56:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/9/2019 5:24:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/9/2019 6:06:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2019 4:08:15 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/24/2019 4:22:59 PM
casenumber   Wednesday, 08/14/19 04:54:41 PM
Re: dirtydozen911 post# 1692
Post # of 1962 
Merck n Sellas Partnership will be next to be updated!

Merck will do logistics/supply/Mfg for Sellas!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist